• Study on Dinutuximab Beta and Drug Combination for Children, Teens, and Adults with GD2-Positive Ewing Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Germany Sweden

  • Study on Preventing Heart Transplant Rejection in Children Using Autologous Treg Cells (thyTreg)

    Recruiting

    1 1 1
    Investigated Diseases:
    Spain

  • Study on the Safety of Anti-GD2 CAR T Cells, Cyclophosphamide, and Fludarabine in Children and Young Adults with Relapsed or Refractory Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece

  • Study on the Effectiveness of Etoposide, Carboplatin, and Cisplatin in Patients with Localized Digestive Neuroendocrine Carcinomas

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France

  • Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

    Recruiting

    3 1 1
    Investigated Drugs:
    Denmark

  • Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Oral Arsenic Trioxide for Patients with Low-Risk Myelodysplastic Syndromes Not Responding to Erythropoiesis Stimulating Agents and Luspatercept

    Recruiting

    1 1 1
    Investigated Drugs:
    France

  • Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by